Repligen (RGEN) Tops Q3 EPS by 4c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $165.89 -1.86%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $189 million versus the consensus estimate of $181.78 million.
GUIDANCE:
Repligen sees FY2025 EPS of $1.65-$1.68, versus the consensus of $1.69. Repligen sees FY2025 revenue of $729-737 million, versus the consensus of $727.8 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber sells part of its Aurora stake in block trade - Bloomberg
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- VNET Group (VNET) Misses Q2 EPS by 164c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
